Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZVS101e in Bietti's Crystalline Dystrophy
NCT06743646Phase 3Active, not recruiting
- Sponsor
- CHIGENOVO
- Start
- Dec 2024
- Primary completion
- Apr 2026
- Modality
- Gene Editing, Gene Silencing, AAV Vectors
- Countries
- 1
01
Overview
A Phase 3 trial of ZVS101e in Bietti crystalline dystrophy (BCD), sponsored by CHIGENOVO. Started Dec 2024; status: active, not recruiting.
02
Drugs
ZVS101e
03
Conditions
Bietti crystalline dystrophy (BCD)
Beyond the preview
Go deeper on NCT06743646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06743646.